LB PHARMACEUTICALS INC - LBRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jul 16, 2026 | SCHEDULE 13G | JPMORGAN CHASE & CO | 5.2% | 1,497,293 | View |
| May 15, 2026 | SCHEDULE 13G/A | TCG Crossover GP II, LLC | 6.4% | 1,839,489 | View |
| May 15, 2026 | SCHEDULE 13G/A | TCG Crossover Fund II, L.P. | 6.4% | 1,839,489 | View |
| May 15, 2026 | SCHEDULE 13G/A | Chen Yu | 6.4% | 1,839,489 | View |
| May 15, 2026 | SCHEDULE 13G/A | Commodore Capital LP | 6.8% | 1,972,369 | View |
| May 15, 2026 | SCHEDULE 13G/A | Commodore Capital Master LP | 6.8% | 1,972,369 | View |
| May 15, 2026 | SCHEDULE 13G/A | Robert Egen Atkinson | 6.8% | 1,972,369 | View |
| May 15, 2026 | SCHEDULE 13G/A | Michael Kramarz | 6.8% | 1,972,369 | View |
| May 15, 2026 | SCHEDULE 13G | Caligan Partners LP | 5.0% | 1,438,070 | View |
| May 15, 2026 | SCHEDULE 13G | JOHNSON DAVID EDWARD | 5.0% | 1,438,070 | View |
| May 13, 2026 | SCHEDULE 13G/A | JPMORGAN CHASE & CO | 4.9% | 1,427,568 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 8.7% | 2,208,604 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 8.7% | 2,208,604 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Rajeev Shah | 8.7% | 2,208,604 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 8.7% | 2,208,604 | View |
| Feb 10, 2026 | SCHEDULE 13D/A | — | 9.99% | 28,605,673 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.